Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Two who served on Theranos’ board acknowledged that they failed to confront Chief Executive Elizabeth Holmes about the allegations because they believed her claims about the technology’s capabilities. (Photo: AP)

(Bloomberg) — Two former Theranos directors said they didn’t think to question executives as allegations arose that the struggling startup used existing blood-testing technology rather than its heralded system to analyze samples.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.